- Incyte CEO sees $2B Vega deal aiding a post-Jakafi futureBill Meury has been in or led the C-suite of several biopharma companies that have constructed multibillion-dollar exits over the past decade: Allergan, Karuna and Anthos. Now, he’s the one buyin…Endpoints · 1mo ago↗ source
- City Therapeutics gets $99M to gather data on three RNAi medicinesCity Therapeutics, the next-gen RNAi startup founded and led by former Alnylam executives, has collected $99.5 million to fund the clinical development of its first three candidates and expand into…Endpoints · 1mo ago↗ source
- Roche stakes $700M on Nurix’s protein-degrading drug<p>Potentially worth up to $2.3 billion, the collaboration is a bet that drugs able to eliminate the “BTK” enzyme will prove superior to existing medicines that block its activity.</p>